Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance

Medical Microbiology and Immunology

Volumn 201, Issue 4, 2012, Pages 581-592

  Kautz Neu, Kordula ^a   Schwonberg, Kirsten ^a   Fischer, Michael R ^a   Schermann, Anja I ^a   von Stebut, Esther ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adaptive immunity; Dendritic cells; Leishmania; Skin immune system

Indexed keywords

FC RECEPTOR;

ANIMAL; ANTIGEN PRESENTATION; B LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNOLOGY; LEISHMANIA MAJOR; LYMPHOCYTE ACTIVATION; MACROPHAGE; METABOLISM; NEUTROPHIL; PARASITOLOGY; PHAGOCYTOSIS; REVIEW; SKIN LEISHMANIASIS; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MACROPHAGES; NEUTROPHILS; PHAGOCYTOSIS; RECEPTORS, IGG; T-LYMPHOCYTES;

EID: 85027958306     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-012-0261-2     Document Type: Review

References (92)

1. Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191–1199
2. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845–858
3. Bogdan C (2012) Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats. Ann Rheum Dis 71:60–66
4. *von Stebut E (2007) Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur J Dermatol 17:115–122
5. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D (2000) A natural model of Leishmania major infection reveals a prolonged “silent” phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165:969–977
6. Peters NC, Sacks DL (2009) The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis. Cell Microbiol 11:1290–1296
7. *von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC (1998) Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 188:1547–1552
8. *von Stebut E, Belkaid Y, Nguyen BV, Cushing M, Sacks DL, Udey MC (2000) Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur J Immunol 30:3498–3506
9. Misslitz AC, Bonhagen K, Harbecke D, Lippuner C, Kamradt T, Aebischer T (2004) Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection. Eur J Immunol 34:715–725
10. Baldwin T, Henri S, Curtis J, O’Keeffe M, Vremec D, Shortman K, Handman E (2004) Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes. Infect Immun 72:1991–2001
11. *von Stebut E (2007) Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy. Exp Dermatol 16:340–346
12. *Woelbing F, Kostka SL, Moelle K, Belkaid Y, Sunderkoetter C, Verbeek S, Waisman A, Nigg AP, Knop J, Udey MC, von Stebut E (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity. J Exp Med 203:177–188
13. + effector T cells and susceptibility to infectious diseases. Adv Exp Med Biol 452:45–52
14. Blank C, Fuchs H, Rappersberger K, Röllinghoff M, Moll H (1993) Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J Infect Dis 167:418–425
15. Flohé SB, Bauer C, Flohé S, Moll H (1998) Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur J Immunol 28:3800–3811
16. Ahuja SS, Mummidi S, Malech HL, Ahuja SK (1998) Human dendritic cell (DC)-based anti-infective therapy: engineering DCs to secrete functional IFN-γ and IL-12. J Immunol 161:868–876
17. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol 168:3992–4000
18. Schönlau F, Scharffetter-Kochanek K, Grabbe S, Pietz B, Sorg C, Sunderkötter C (2000) In experimental leishmaniasis deficiency of CD18 results in parasite dissemination associated with altered macrophage functions and incomplete Th1 cell response. Eur J Immunol 30:2729–2740
19. Köhl J (2006) Self, non-self, and danger: a complementary view. Adv Exp Med Biol 586:71–94
20. Domínguez M, Toraño A (1999) Immune adherence-mediated opsonophagocytosis: the mechanism of Leishmania infection. J Exp Med 189:25–35
21. *Lopez Kostka S, Dinges S, Griewank K, Iwakura Y, Udey MC, von Stebut E (2009) IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol 182:3039–3046
22. Miles SA, Conrad SM, Alves RG, Jeronimo SM, Mosser DM (2005) A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med 201:747–754
23. Editor’s Choice (2006) Primed by parasites. Science 311:579–581
24. Wanderley JL, Barcinski MA (2010) Apoptosis and apoptotic mimicry: the Leishmania connection. Cell Mol Life Sci 67:1653–1659
25. Wanderley JL, Moreira ME, Benjamin A, Bonomo AC, Barcinski MA (2006) Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts. J Immunol 176:1834–1839
26. *Maurer M, Lopez Kostka S, Siebenhaar F, Moelle K, Metz M, Knop J, von Stebut E (2006) Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J 20:2460–2467
27. Wershil BK, Theodos CM, Galli SJ, Titus RG (1994) Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 152:4563–4571
28. Bidri M, Vouldoukis I, Mossalayi MD, Debre P, Guillosson JJ, Mazier D, Arock M (1997) Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol 19:475–483
29. Grimaldi G Jr, Soares MJ, Moriearty PL (1984) Tissue eosinophilia and Leishmania mexicana eosinophil interactions in murine cutaneous leishmaniasis. Parasite Immunol 6:397–408
30. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8:1095–1104
31. *Dudeck A, Suender CA, Kostka SL, von Stebut E, Maurer M (2011) Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur J Immunol 41:1883–1893
32. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, Lawyer P, Fay MP, Germain RN, Sacks D (2008) In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321:970–974
33. Laskay T, van Zandbergen G, Solbach W (2008) Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology 213:183–191
34. John B, Hunter CA (2008) Immunology. Neutrophil soldiers or Trojan Horses? Science 321:917–918
35. Ribeiro-Gomes FL, Peters NC, Debrabant A, Sacks DL (2012) Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-Leishmania response. PLoS Pathog 8:e1002536
36. *von Stebut E, Metz M, Milon G, Knop J, Maurer M (2003) Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell-derived TNFα. Blood 101:210–215
37. Suto H, Nakae S, Kakurai M, Sedgwick JD, Tsai M, Galli SJ (2006) Mast cell-associated TNF promotes dendritic cell migration. J Immunol 176:4102–4112
38. Bryce PJ, Miller ML, Miyajima I, Tsai M, Galli SJ, Oettgen HC (2004) Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20:381–392
39. Jawdat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS (2004) IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 173:5275–5282
40. Mekori YA, Metcalfe DD (1999) Mast cell-T cell interactions. J Allergy Clin Immunol 104:517–523
41. Nakano N, Nishiyama C, Kanada S, Niwa Y, Shimokawa N, Ushio H, Nishiyama M, Okumura K, Ogawa H (2007) Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood 109:4846–4855
42. Mitchell GF (1983) Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major. J Immunogenet 10:395–412
43. Holaday BJ, Sadick MD, Wang Z-E, Reiner SL, Heinzel FP, Parslow TG, Locksley RM (1991) Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like lines. J Immunol 147:1653–1658
44. Locksley RM, Reiner SL, Hatam F, Littman DR, Killeen N (1993) Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261:1448–1451
45. Titus RG, Ceredig R, Cerottini JC, Louis JA (1985) Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol 135:2108–2114
46. + T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol 17:1429–1433
47. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 88:7011–7015
48. Mougneau E, Altare F, Wakil AE, Zheng S, Coppola T, Wang ZE, Waldmann R, Locksley RM, Glaichenhaus N (1995) Expression cloning of a protective Leishmania antigen. Science 268:563–566
49. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989) Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169:59–72
50. + T cells following secondary infection of mice immune to Leishmania major. Infect Immun 62:2575–2581
51. + T cells do not mediate a protective immune response. Immunobiology 195:243–260
52. + T cells. J Exp Med 199:1559–1566
53. + T cell-mediated immunity against Leishmania major. J Invest Dermatol 130:2602–2610
54. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P (1987) Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 166:1654–1667
55. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM (1990) Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172:1483
56. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana CJ (1990) Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 145:2833–2838
57. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, Ahuja SS (2000) CC chemokine receptor (CCR) 2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192:205–218
58. Moll H, Fuchs H, Blank C, Röllinghoff M (1993) Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 23:1595–1601
59. + T cells during initiation of infection. J Exp Med 179:447–456
60. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Müller W, Kühn R, Sacks DL (1996) Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 183:515–526
61. Ramachandra L, Boom WH, Harding CV (2008) Class II MHC antigen processing in phagosomes. Methods Mol Biol 445:353–377
62. + T cells by Leishmania major-infected dendritic cells. Infect Immun 73:6620–6628
63. + T-cell tolerance by cross-presentation of self antigens. Immunol Rev 165:267–277
64. − dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192:1685–1696
65. Kloetzel PM (2001) Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2:179–187
66. Kalergis AM, Ravetch JV (2002) Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 195:1653–1659
67. + T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J Immunol 177:3525–3533
68. + T cells in vivo does not require LMP7-containing immunoproteasomes. J Invest Dermatol 132:1302–1305
69. + T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J Immunol 182:774–783
70. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG (1993) Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 177:1797–1802
71. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK (1993) Recombinant interleukin-12 cures mice infected with Leishmania major. J Exp Med 177:1505–1509
72. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G (1996) Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 26:1553–1559
73. Heinzel FP, Rerko RM, Ahmed F, Pearlman E (1995) Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol 155:730–739
74. *von Stebut E (2011) Research in practice: different dendritic cell types in skin with various functions—important implications for intradermal vaccines. J Dtsch Dermatol Ges 9:506–509
75. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, Vicari A, O’Garra A, Biron C, Briere F, Trinchieri G (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2:1144–1150
76. Wu L, Dakic A (2004) Development of dendritic cell system. Cell Mol Immunol 1:112–118
77. Wilson NS, El Sukkari D, Belz GT, Smith CM, Steptoe RJ, Heath WR, Shortman K, Villadangos JA (2003) Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102:2187–2194
78. Leon B, Lopez-Bravo M, Ardavin C (2007) Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26:519–531
79. Valladeau J, Clair-Moninot V, Dezutter-Dambuyant C, Pin JJ, Kissenpfennig A, Mattei MG, Ait-Yahia S, Bates EE, Malissen B, Koch F, Fossiez F, Romani N, Lebecque S, Saeland S (2002) Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 168:782–792
80. Takahara K, Omatsu Y, Yashima Y, Maeda Y, Tanaka S, Iyoda T, Clausen BE, Matsubara K, Letterio J, Steinman RM, Matsuda Y, Inaba K (2002) Identification and expression of mouse Langerin (CD207) in dendritic cells. Int Immunol 14:433–444
81. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N, Tripp CH, Douillard P, Leserman L, Kaiserlian D, Saeland S, Davoust J, Malissen B (2005) Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22:643–654
82. Douillard P, Stoitzner P, Tripp CH, Clair-Moninot V, Ait-Yahia S, McLellan AD, Eggert A, Romani N, Saeland S (2005) Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J Invest Dermatol 125:983–994
83. + dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 204:3119–3131
84. + dendritic cells survey the skin in the steady state. J Exp Med 204:3133–3146
85. + dendritic cells. J Exp Med 204:3147–3156
86. + dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 207:189–206
87. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, Clausen BE (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169:569–576
88. + dermal dendritic cells in contact hypersensitivity. J Invest Dermatol 130:2752–2759
89. *Kautz-Neu K, Noordegraaf M, Dinges S, Bennett CL, John D, Clausen BE, von Stebut E (2011) Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 208:885–891
90. *von Stebut E, Ehrchen JM, Belkaid Y, Kostka SL, Molle K, Knop J, Sunderkotter C, Udey MC (2003) Interleukin 1α promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J Exp Med 198:191–199
91. + T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med 198:201–209
92. *Zahn S, Wirtz S, Birkenbach M, Blumberg RS, Neurath MF, von Stebut E (2005) Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major. Eur J Immunol 35:1106–1112